Pyxis Tankers beat estimated earnings by 5.26%, reporting an EPS of $0.2 versus an estimate of $0.19. Revenue was down $1.50 million from the same period last year. During the previous quarter, the ...
BOSTON, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced ...
BOSTON, May 30, 2023 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today ...
Pyxis Oncology (NASDAQ:PYXS), a biopharmaceutical company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment, has been garnering attention from investors and ...
Pyxis Tankers Inc (NASDAQ:PXS) chairman and CEO Valentios (Eddie) Valentis speaks to Thomas Warner from Proactive about how the tanker operator has been performing since his last Proactive appearance ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results